about
Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for CancerExpression of the thioredoxin system in an in vivo-like cancer cell environment upon auranofin treatment.TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition.Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myelomaCross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.The Multifaceted Roles of DJ-1 as an Antioxidant.Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation.CEP55 is a determinant of cell fate during perturbed mitosis in breast cancerAnticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myelomaTherapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancerGSK3-β Stimulates Claspin Degradation via β-TrCP Ubiquitin Ligase and Alters Cancer Cell Survival
P50
Q28083118-57D64E06-2F91-4B12-B601-7D34589D632CQ38749712-2BC8B411-8441-4083-8A7F-64B0962DE4FBQ38805723-F42353B6-F3E8-4A75-9ABB-DB15E14F99A8Q38878577-5558DDE5-FEF0-4CA7-A79A-9475E571B5A3Q41882913-163EE61C-6EC1-4EB0-9D1D-346AA280D5F4Q46259811-399F620E-A6F1-481A-956E-9358886AC83EQ48955308-6B30DF02-BBF8-4703-9838-08FCF9691FFCQ58779939-12048FD5-62BA-49D7-A4D5-9E21C43AB251Q90078100-A53C2E61-22B0-42C0-AD7C-B4F0F60E6827Q92030580-BD41772E-3411-42F0-B06D-CE31905E149AQ92290872-63A1551C-11A6-40AA-BB6E-238DFBA6127A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Prahlad V Raninga
@en
Prahlad V Raninga
@nl
type
label
Prahlad V Raninga
@en
Prahlad V Raninga
@nl
prefLabel
Prahlad V Raninga
@en
Prahlad V Raninga
@nl
P31
P496
0000-0003-3013-6526